Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

The European Commission approved QDENGA (TAK-003) for use in individuals four years of age and older QDENGA becomes the only dengue vaccine approved in the EU for use in individuals regardless of previous dengue exposure Takeda (TSE:4502/NYSE:TAK) today announced that...

Read more
Page 118 of 136 1 117 118 119 136